Figure 2
![Figure 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1742-4682-2-19/MediaObjects/12976_2005_Article_32_Fig2_HTML.jpg)
Predicted dose-response curves in case of skeletal muscle. The star symbol (*) represents the experimental data from Beavo et al. [35]. (A) Dose-response curves in the presence of inhibition of PP1 by inhibitor-1. The sensitivity of the fractional dose-response curve of glycogen synthase (curve a, Apparent Hill coefficient ~6.4), glycogen phosphorylase (curve b,
~33.8), phosphorylase kinase (curve c,
~7), inhibitor-1 (curve d,
~1.3), CAPK activation (curve e,
~1.12). (B) Dose-response curves in absence of inhibition of PP1 by inhibitor-1. The sensitivity fractional dose-response curve of Glycogen synthase (curve a,
~1.2); Glycogen phosphorylase (curve b,
~3.8); Phosphorylase kinase (curve c,
~0.8); Inhibitor-1 (curve d:
~1.3); CAPK activation (curve e,
~1.12).